Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-20-053155

President and CEO gave up 6,239 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-30 Shares withheld for taxes : show line 1 in the form −6,239 $1.66 $10,357 1,309,727 D
Loading xslF345X03/doc4.xml…